AI-generated summary
The authors reviewed randomized trials comparing low level laser therapy plus antituberculous drugs with antituberculous drugs alone for tuberculosis. They identified only one eligible trial of 130 participants from India, which was poorly reported and could not be analyzed for its key outcomes. The authors report that the use of low level laser therapy for tuberculosis is still not supported by reliable evidence.
- Participants
- 130
- Studies included
- 1
- Who or what was studied
- People with tuberculosis
- Limits stated in the abstract
- Only one poorly reported trial met the inclusion criteria, with unclear allocation methods and missing group data that prevented analysis of outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.